Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
83
Views
3
CrossRef citations to date
0
Altmetric
Original Research

A Novel Circular RNA circPTCD3 Promotes Breast Cancer Progression Through Sponging miR-198

Zhaohui Zhang1 Department of Tumor Chemotherapy and Radiation Sickness, Peking University Third Hospital, Beijing, 100191, People’s Republic of ChinaCorrespondence[email protected]
,
Hao Hu2 Beijing 100biotech Co., Ltd., Beijing, 100006, People’s Republic of China
,
Qian Li1 Department of Tumor Chemotherapy and Radiation Sickness, Peking University Third Hospital, Beijing, 100191, People’s Republic of China
,
Fumei Yi1 Department of Tumor Chemotherapy and Radiation Sickness, Peking University Third Hospital, Beijing, 100191, People’s Republic of China
&
Yan’e Liu1 Department of Tumor Chemotherapy and Radiation Sickness, Peking University Third Hospital, Beijing, 100191, People’s Republic of China
Pages 8435-8443 | Published online: 10 Nov 2021

References

  • Woolston C. Breast cancer. Nature. 2015;527(7578):S101. doi:10.1038/527S101a26580154
  • Cook DJ, Kallus J, Jornsten R, Nielsen J. Molecular natural history of breast cancer: leveraging transcriptomics to predict breast cancer progression and aggressiveness. Cancer Med. 2020;9(10):3551–3562. doi:10.1002/cam4.299632207233
  • Khandekar D, Tiriveedhi V. Role of BET inhibitors in triple negative breast cancers. Cancers. 2020;12(4):784. doi:10.3390/cancers12040784
  • Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL. CircRNA: a novel type of biomarker for cancer. Breast Cancer Tokyo. 2018;25(1):1–7. doi:10.1007/s12282-017-0793-9
  • Agostini M, Ganini C, Candi E, Melino G. The role of noncoding RNAs in epithelial cancer. Cell Death Discov. 2020;6(1):13. doi:10.1038/s41420-020-0247-632194993
  • Wei L, Sun J, Zhang N, et al. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19(1):62. doi:10.1186/s12943-020-01185-732192494
  • Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388. doi:10.1080/15476286.2015.102027125746834
  • Hua JT, Chen S, He HH. Landscape of noncoding RNA in prostate cancer. Trends Genet. 2019;35(11):840–851. doi:10.1016/j.tig.2019.08.00431623872
  • Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis. 2015;35(1):3–11. doi:10.1055/s-0034-139734425632930
  • Lou W, Ding B, Fu P. Pseudogene-derived lncRNAs and their miRNA sponging mechanism in human cancer. Front Cell Dev Biol. 2020;8:85. doi:10.3389/fcell.2020.0008532185172
  • Wu J, Jiang Z, Chen C, et al. CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis. Cancer Lett. 2018;430:179–192. doi:10.1016/j.canlet.2018.05.03329803789
  • Du WW, Yang W, Li X, et al. A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy. Oncogene. 2018;37(44):5829–5842. doi:10.1038/s41388-018-0369-y29973691
  • Liu Z, Zhou Y, Liang G, et al. Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. Cell Death Dis. 2019;10(2):55. doi:10.1038/s41419-018-1287-130670688
  • Liang Y, Song X, Li Y, et al. circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer. Oncogene. 2019;38(42):6850–6866. doi:10.1038/s41388-019-0926-z31406252
  • Cao L, Wang M, Dong Y, et al. Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1alpha/HK2. Cell Death Dis. 2020;11(2):145. doi:10.1038/s41419-020-2336-032094325
  • Huang W, Yang Y, Wu J, et al. Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-beta signalling. Cell Death Differ. 2019.
  • Min J, Han TS, Sohn Y, et al. microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2. Gastric Cancer. 2020;23(4):600–613. doi:10.1007/s10120-020-01052-w32112274
  • He M, Jin Q, Chen C, et al. The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells. Oncogene. 2019;38(28):5551–5565. doi:10.1038/s41388-019-0817-330967627
  • Ren L, Chen H, Song J, et al. MiR-454-3p-Mediated Wnt/beta-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis. Theranostics. 2019;9(2):449–465. doi:10.7150/thno.2905530809286
  • Wu Y, Shi W, Tang T, et al. miR-29a contributes to breast cancer cells epithelial–mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2. Cell Death Dis. 2019;10(3):176. doi:10.1038/s41419-019-1437-030792382
  • Niu L, Zhou Y, Zhang W, Ren Y. Long noncoding RNA LINC00473 functions as a competing endogenous RNA to regulate MAPK1 expression by sponging miR-198 in breast cancer. Pathol Res Pract. 2019;215(8):152470. doi:10.1016/j.prp.2019.15247031201066
  • Hu Y, Tang Z, Jiang B, Chen J, Fu Z. miR-198 functions as a tumor suppressor in breast cancer by targeting CUB domain-containing protein 1. Oncol Lett. 2017;13(3):1753–1760. doi:10.3892/ol.2017.567328454320
  • Caiment F, Gaj S, Claessen S, Kleinjans J. High-throughput data integration of RNA-miRNA-circRNA reveals novel insights into mechanisms of benzo[a]pyrene-induced carcinogenicity. Nucleic Acids Res. 2015;43(5):2525–2534. doi:10.1093/nar/gkv11525690898

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.